187 related articles for article (PubMed ID: 28821270)
1. Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion.
Qin S; Ingle JN; Liu M; Yu J; Wickerham DL; Kubo M; Weinshilboum RM; Wang L
Breast Cancer Res; 2017 Aug; 19(1):95. PubMed ID: 28821270
[TBL] [Abstract][Full Text] [Related]
2. ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion.
Qin S; Ingle JN; Kim W; Gao H; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2021 Sep; 31(7):155-164. PubMed ID: 34001842
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
Wang G; Qin S; Zayas J; Ingle JN; Liu M; Weinshilboum RM; Shen K; Wang L
Breast Cancer Res Treat; 2019 Jun; 175(3):567-578. PubMed ID: 30937657
[TBL] [Abstract][Full Text] [Related]
4. Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.
Ingle JN; Liu M; Wickerham DL; Schaid DJ; Wang L; Mushiroda T; Kubo M; Costantino JP; Vogel VG; Paik S; Goetz MP; Ames MM; Jenkins GD; Batzler A; Carlson EE; Flockhart DA; Wolmark N; Nakamura Y; Weinshilboum RM
Cancer Discov; 2013 Jul; 3(7):812-25. PubMed ID: 23764426
[TBL] [Abstract][Full Text] [Related]
5. SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
Cairns J; Ingle JN; Wickerham LD; Weinshilboum R; Liu M; Wang L
PLoS Genet; 2017 Oct; 13(10):e1007031. PubMed ID: 28968398
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor α antagonism.
Wu J; Yan J; Fang P; Zhou HB; Liang K; Huang J
Cancer Lett; 2020 Jan; 469():78-88. PubMed ID: 31629931
[TBL] [Abstract][Full Text] [Related]
7. ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer.
Bond HM; Scicchitano S; Chiarella E; Amodio N; Lucchino V; Aloisio A; Montalcini Y; Mesuraca M; Morrone G
Front Endocrinol (Lausanne); 2018; 9():255. PubMed ID: 29867779
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the
Liu D; Ho MF; Schaid DJ; Scherer SE; Kalari K; Liu M; Biernacka J; Yee V; Evans J; Carlson E; Goetz MP; Kubo M; Wickerham DL; Wang L; Ingle JN; Weinshilboum RM
NPJ Breast Cancer; 2017; 3():30. PubMed ID: 28856246
[TBL] [Abstract][Full Text] [Related]
9. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
[TBL] [Abstract][Full Text] [Related]
10. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.
Hato Y; Kondo N; Yoshimoto N; Endo Y; Asano T; Dong Y; Nishimoto M; Takahashi S; Fujii Y; Nakanishi R; Toyama T
Int J Clin Oncol; 2016 Jun; 21(3):539-47. PubMed ID: 26482374
[TBL] [Abstract][Full Text] [Related]
12.
Ho MF; Ingle JN; Bongartz T; Kalari KR; Goss PE; Shepherd LE; Mushiroda T; Kubo M; Wang L; Weinshilboum RM
Mol Pharmacol; 2017 Aug; 92(2):175-184. PubMed ID: 28615284
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.
Wardell SE; Ellis MJ; Alley HM; Eisele K; VanArsdale T; Dann SG; Arndt KT; Primeau T; Griffin E; Shao J; Crowder R; Lai JP; Norris JD; McDonnell DP; Li S
Clin Cancer Res; 2015 Nov; 21(22):5121-5130. PubMed ID: 25991817
[TBL] [Abstract][Full Text] [Related]
15. Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.
Ho MF; Bongartz T; Liu M; Kalari KR; Goss PE; Shepherd LE; Goetz MP; Kubo M; Ingle JN; Wang L; Weinshilboum RM
Mol Endocrinol; 2016 Mar; 30(3):382-98. PubMed ID: 26866883
[TBL] [Abstract][Full Text] [Related]
16. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
Sheng S; Barnett DH; Katzenellenbogen BS
Mol Cell Endocrinol; 2008 Dec; 296(1-2):1-9. PubMed ID: 18951949
[TBL] [Abstract][Full Text] [Related]
17. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.
Traphagen NA; Schwartz GN; Tau S; Roberts AM; Jiang A; Hosford SR; Marotti JD; Goen AE; Romo BA; Johnson AL; Duffy EK; Demidenko E; Heverly P; Mosesson Y; Soucy SM; Kolling F; Miller TW
Clin Cancer Res; 2023 Sep; 29(18):3717-3728. PubMed ID: 37439680
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics.
Cirillo F; Nassa G; Tarallo R; Stellato C; De Filippo MR; Ambrosino C; Baumann M; Nyman TA; Weisz A
J Proteome Res; 2013 Jan; 12(1):421-31. PubMed ID: 23170835
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptor modulation--role of coregulators in selective estrogen receptor modulator (SERM) actions.
Feng Q; O'Malley BW
Steroids; 2014 Nov; 90():39-43. PubMed ID: 24945111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
